SCHEMBL7102817

SCHEMBL7102817

CCOC(=O)C(C(=O)OCC)c1cccc(-c2c(C)ccc(C)c2Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP8 P22894 1/20 0.42
▸ CTSA P10619 6/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ GPR35 Q9HC97 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ GRM6 O15303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL812910 0.87 CTSA (0.54) MMP8CTSAGPR35ALDH1A1MAPT
SCHEMBL1274044 0.82 CTSA (0.52) MMP8CTSASMN1; SMN2ALDH1A1MAPT
SCHEMBL9052329 0.77 MMP8 (0.50) MMP8SMN1; SMN2ALDH1A1MAPTRAB9A
SCHEMBL1491141 0.74 MMP8 (0.53) MMP8CA12CA1CA2CA9
SCHEMBL1274836 0.73 MEN1 (0.45) CTSAMAPTKDM4EMEN1KMT2A
SCHEMBL28225086 0.72 MMP8 (0.48) MMP8CA12CA1CA2CA9
SCHEMBL290364 0.71 MMP8 (0.54) MMP8CTSAALDH1A1MAPTHPGD
SCHEMBL29824513 0.71 MMP8 (0.54) MMP8CTSAALDH1A1MAPTHPGD
SCHEMBL20346320 0.71 MMP8 (0.50) MMP8SMN1; SMN2CA12CA1CA2
SCHEMBL15645799 0.71 MMP8 (0.50) MMP8SMN1; SMN2MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030096806-A1 Arylphenyl-substituted cyclic ketoenols LIEB FOLKER (DE) 2003-05-22 — — US disclosed
US-6451843-B1 Arylphenyl-substituted cyclic keto enols BAYER AKTIENGESELLSCHAFT (DE) 2002-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096806-A1 Arylphenyl-substituted cyclic ketoenols KCNE1, KCNQ3, SULT1E1 MMP8 4457/4885CTSA 3365/4885SMN1; SMN2 4637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback